evrotas
 

URIVAC

URIVAC - original patented immunomodulation product. URIVAC - support of immune system, especially of the urinary tract. URIVAC contains a dose for three months in one packaging.

Infection of kidneys and urinary tracts are not serious, but very unpleasant conditions. These include acute and chronic urinary tract infections, infections of urethra, urether and kidney pelvis.

The most frequent cause of non-specific bacterial urinary tract infections include e.g. gram-negative rods, staphylococci or enterococci.

Development of these urinary tract infections is influenced by various predisposition factors (anatomic and physiological differences related to gender with more frequent occurrence in women, pregnancy, urinary tract obstructions or impaired outflow of urine, inflammatory lesions in the surrounding area, disorders of metabolism, etc.).

Urinary tract infection affects every other woman at least once in a life. Complaints subside spontaneously or antibiotics may help. If the inflammation recurs, the cause may be a disorder of immunity.

One of the methods to enhance general immune defence of the organism and of the urinary tract is modulation of the immune mechanisms using URIVAC. URIVAC is a patented product developed in cooperation with specialists from the Medical Faculty of the Palacky University in Olomouc.

It contains harmless parts of bacteria, which are frequently responsible for urinary tract infections and which stimulate immunity and thereby support the natural defence of the organism.



Photo:
URIVAC
Info

Product manufactured by:

Bioveta, a.s.

Presentation available at:

CZ | EN |
> About the project     > Add FREE    
Other languages:   EN    DE    CZ    PL    FR
TOPlist